-
1.
公开(公告)号:US20240306989A1
公开(公告)日:2024-09-19
申请号:US18674684
申请日:2024-05-24
Applicant: NeuroPace, Inc.
Inventor: Tara L. Crowder , Brett M. Wingeier , Martha J. Morrell , Felice Sun , Thomas Tcheng
IPC: A61B5/00 , A61B5/145 , A61B5/1455 , A61B5/24 , A61B5/377
CPC classification number: A61B5/4848 , A61B5/0002 , A61B5/0031 , A61B5/24 , A61B5/377 , A61B5/0022 , A61B5/14539 , A61B5/14553 , A61B5/4082 , A61B5/4094
Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.
-
公开(公告)号:US12029581B2
公开(公告)日:2024-07-09
申请号:US17346944
申请日:2021-06-14
Applicant: NeuroPace, Inc.
Inventor: Tara L. Crowder , Brett M. Wingeier , Martha J. Morrell , Felice Sun , Thomas Tcheng
IPC: A61B5/00 , A61B5/24 , A61B5/377 , A61B5/145 , A61B5/1455
CPC classification number: A61B5/4848 , A61B5/0002 , A61B5/0031 , A61B5/24 , A61B5/377 , A61B5/0022 , A61B5/14539 , A61B5/14553 , A61B5/4082 , A61B5/4094
Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.
-
公开(公告)号:US20220323019A1
公开(公告)日:2022-10-13
申请号:US17709159
申请日:2022-03-30
Applicant: NeuroPace, Inc.
Inventor: Sharanya Arcot Desai , Tara L. Crowder , Thomas K. Tcheng , Martha J. Morrell , Lise Johnson Dyhr
Abstract: A clinical response estimate (CRE) biomarker of a patient having an implanted neurostimulation system is monitored. To this end, an input dataset is derived from a subject-patient dataset that includes various different data types and different features of the patient. The data types are based on electrical activity the patient's brain sensed and stored by the implanted neurostimulation system. The input dataset is a subset of the larger subject-patient dataset, and the specific data types and patient features included in that subset are derived based on a plurality of key inputs of the subject-patient dataset. Once the input dataset is derived, it is processed by a clinical response estimator having machine-learned models. First and second machine-learned models of the clinical response estimator are applied to the input dataset to provide model inputs to an ensemble machine-learned model to determine the CRE biomarker.
-
公开(公告)号:US20220313159A1
公开(公告)日:2022-10-06
申请号:US17709195
申请日:2022-03-30
Applicant: NeuroPace, Inc.
Inventor: Sharanya Arcot Desai , Tara L. Crowder , Thomas K. Tcheng , Martha J. Morrell , Lise Johnson Dyhr
Abstract: An input dataset is processed to obtain a pre-event window of model inputs and a post-event window of model inputs. The input dataset is a subset of a larger subject-patient dataset that includes different data types and features of the patient. The data types are based on electrical activity of the patient's brain that is sensed and stored by an implanted neurostimulation system. A clinical response estimator (CRE) model is applied to the pre-event window of model inputs to derive pre-event CRE biomarkers. The CRE model is also applied to the post-event window of model inputs to derive post-event CRE biomarkers. The pre-event CRE biomarkers and post-event CRE biomarkers are displayed as a function of time together with the occurrence of the event of interest.
-
公开(公告)号:US11064926B2
公开(公告)日:2021-07-20
申请号:US15817160
申请日:2017-11-17
Applicant: NeuroPace, Inc.
Inventor: Tara L. Crowder , Brett M. Wingeier , Martha J. Morrell , Felice Sun , Thomas Tcheng
IPC: A61B5/00 , A61B5/24 , A61B5/377 , A61B5/145 , A61B5/1455
Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.
-
公开(公告)号:US09265931B2
公开(公告)日:2016-02-23
申请号:US14845153
申请日:2015-09-03
Applicant: NeuroPace, Inc.
Inventor: Martha J. Morrell
IPC: A61N1/05 , A61B5/04 , A61B5/0402 , A61B5/00 , A61N1/36
CPC classification number: A61N1/36082 , A61B5/04001 , A61B5/0402 , A61B5/0476 , A61B5/165 , A61B5/4094 , A61B5/4836 , A61B5/6868 , A61B5/7282 , A61N1/0529 , A61N1/0531 , A61N1/0539 , A61N1/36135
Abstract: Methods of treating language, behavioral and social disorders are described, including methods of treating language disorders associated with electrographic abnormalities in the primary or associative language cortex of persons with autism spectrum disorders, pervasive developmental delay or acquired epileptic aphasia. A language, behavioral and social disorder may be treated by detecting epileptiform activity or an electrographic seizure for a subject's brain and applying neurostimulation to a language cortical region of the subject's brain (e.g., a primary or associative language cortical region). Detection of epileptiform activity or an electrographic seizure and stimulation of language cortex may be performed by a sensing and/or stimulation electrode that is inserted into a subject's brain and connected to one or more neurostimulation devices for monitoring and/or stimulating the language cortex.
-
公开(公告)号:US20230172529A1
公开(公告)日:2023-06-08
申请号:US18070902
申请日:2022-11-29
Applicant: NeuroPace, Inc.
Inventor: Sharanya Arcot Desai , Thomas K. Tcheng , Cairn G. Seale , Martha J. Morrell , David A. Greene
CPC classification number: A61B5/4094 , A61B5/7264 , G16H20/40 , A61B5/6868
Abstract: A method of assessing electrical activity of a brain includes, for each of a plurality of electrical-activity records of the brain, applying a machine-learned ESC model to the record to classify the record as one of a seizure record or a non-seizure record, wherein each of record is sensed by a corresponding one of a plurality of sensing channels of an implanted medical device; for each seizure record in a set of seizure records, applying the machine-learned ESC model to the seizure record to classify the seizure record as one of a local-seizure record or a spread-seizure record, wherein the seizure record comprises a first seizure record captured by a first sensing channel and a second seizure record captured by a second sensing channel; and for each spread-seizure record in a set of spread-seizure records, applying a machine-learned SSC model to the spread-seizure record to classify the spread-seizure record as a type of seizure spread pattern.
-
公开(公告)号:US20210298654A1
公开(公告)日:2021-09-30
申请号:US17346944
申请日:2021-06-14
Applicant: NeuroPace, Inc.
Inventor: Tara L. Crowder , Brett M. Wingeier , Martha J. Morrell , Felice Sun , Thomas Tcheng
Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.
-
9.
公开(公告)号:US20180085015A1
公开(公告)日:2018-03-29
申请号:US15817160
申请日:2017-11-17
Applicant: NeuroPace, Inc.
Inventor: Tara L. Crowder , Brett M. Wingeier , Martha J. Morrell , Felice Sun , Thomas Tcheng
IPC: A61B5/04 , A61B5/00 , A61B5/0484 , A61B5/1455 , A61B5/145
CPC classification number: A61B5/04 , A61B5/0002 , A61B5/0022 , A61B5/04001 , A61B5/0484 , A61B5/14539 , A61B5/14553 , A61B5/4082 , A61B5/4094 , A61B5/4848
Abstract: Systems and methods rely on feedback from an active medical device or devices (e.g., neurostimulator coupled to sensing and stimulation elements such as electrodes) to assess the effectiveness of a patient's drug regimen. Such reliance may include analyzing characteristics in physiological data acquired by the medical device(s), for example, in the form of responses evoked from the patient by electrical stimulation waveforms. Systems and methods further involved adjusting one or more parameters according to which a combination therapy consisting of at least a drug regimen and an electrical stimulation therapy are delivered to a patient, in an effort to optimize the therapeutic effect of the combination. The adjustments may be automatically by one or more implanted or external hosts working together or alone, and/or with the input of a physician.
-
公开(公告)号:US09265946B2
公开(公告)日:2016-02-23
申请号:US14846382
申请日:2015-09-04
Applicant: NeuroPace, Inc.
Inventor: Martha J. Morrell
CPC classification number: A61N1/36082 , A61B5/04001 , A61B5/0402 , A61B5/0476 , A61B5/165 , A61B5/4094 , A61B5/4836 , A61B5/6868 , A61B5/7282 , A61N1/0529 , A61N1/0531 , A61N1/0539 , A61N1/36135
Abstract: Methods of treating language, behavioral and social disorders are described, including methods of treating language disorders associated with electrographic abnormalities in the primary or associative language cortex of persons with autism spectrum disorders, pervasive developmental delay or acquired epileptic aphasia. A language, behavioral and social disorder may be treated by detecting epileptiform activity or an electrographic seizure for a subject's brain and applying neurostimulation to a language cortical region of the subject's brain (e.g., a primary or associative language cortical region). Detection of epileptiform activity or an electrographic seizure and stimulation of language cortex may be performed by a sensing and/or stimulation electrode that is inserted into a subject's brain and connected to one or more neurostimulation devices for monitoring and/or stimulating the language cortex.
-
-
-
-
-
-
-
-
-